MENU
SYRS
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Syros Pharmaceuticals (SYRS) Ownership - Who owns Syros Pharmaceuticals?

Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.73K
P/E Ratio
6.87
Total Cash
58.28M
Projected Growth
N/A
Total Debt
60.23M
Revenue
386K
Risk (Beta)
3.32
Dividend Yield
N/A
Total Cash/Share
2.17
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a therapeutics company focusing on discovering and developing novel gene control therapies

Industry Biotechnology

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Who owns Syros Pharmaceuticals? SYRS symbol Ownership - Tickeron.com